AI assistant
Sending…
Simcere Pharmaceutical Group Limited — Board/Management Information 2021
Mar 31, 2021
48856_rns_2021-03-31_3de086ad-cf1b-4e06-a3e0-5f578e9e3a0e.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [44 x 35] intentionally omitted <==
Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司
(Incorporated in Hong Kong with limited liability)
(Stock code: 2096)
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
The members of the board of directors (the “ Director(s) ”) of Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司 (the “ Board ”) are set out below:
Executive Directors
-
Mr. REN Jinsheng (Chairman)
-
Mr. WAN Yushan
-
Mr. TANG Renhong
Non-executive Director
Mr. ZHAO John Huan
Independent Non-executive Directors
-
Mr. SONG Ruilin
-
Mr. WANG Jianguo
-
Mr. WANG Xinhua
The Board has established four committees. The members of the respective board committees are set out below:
| Committee Directors |
Audit Committee |
Remuneration and Appraisal Committee |
Nomination Committee |
Strategy Committee |
|---|---|---|---|---|
| Mr. REN Jinsheng | Member | Member | Chairman | |
| Mr. WAN Yushan | ||||
| Mr. TANG Renhong | ||||
| Mr. ZHAO John Huan | Member | |||
| Mr. SONG Ruilin | Member | Chairman | ||
| Mr. WANG Jianguo | Member | Chairman | Member | Member |
| Mr. WANG Xinhua | Chairman | Member |
Hong Kong March 31, 2021
More from Simcere Pharmaceutical Group Limited
Transaction in Own Shares
2026
May 22
Report Publication Announcement
2026
May 21
Report Publication Announcement
2026
May 21
Proxy Solicitation & Information Statement
2026
May 21
Proxy Solicitation & Information Statement
2026
May 21
Proxy Solicitation & Information Statement
2026
May 21
Transaction in Own Shares
2026
May 21
Transaction in Own Shares
2026
May 20
Transaction in Own Shares
2026
May 19
Transaction in Own Shares
2026
May 19